Maciej Trzaskowski

Maciej Trzaskowski

Auto-generated profile, based on publicly available information

Maciej Trzaskowski

Max Kelsen, Brisbane, Australia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2018 in Nature Genetics
Verified
Journal Article
Open access
PDF file
NWNaomi R. Wray
Naomi R. Wray
SRStephan Ripke
Stephan Ripke
MMManuel Mattheisen
Manuel Mattheisen
MTMaciej Trzaskowski
Maciej Trzaskowski
EBEnda M. Byrne
Enda M. Byrne
EQEqtlgen
Eqtlgen
Major depressive disorder (MDD) is a common illness accompanied by considerable morbidity, mortality, costs, and heightened risk of suicide. We conducted a genome-wide association meta-analysis based in 135,458 cases and 344,901 controls and identified 44 independent and significant loci. The genetic findings were associated with clinical features of major depression and implicated brain regions exhibiting anatomical differences in cases. Targets of antidepressant medications and genes involved in gene splicing were enriched for smaller association signal. We found important relationships of genetic risk for major depression with educational attainment, body mass, and schizophrenia: lower educational attainment and higher body mass were putatively causal, whereas major depression and schizophrenia reflected a partly shared biological etiology. All humans carry lesser or greater numbers of genetic risk factors for major depression. These findings help refine the basis of major depression and imply that a continuous measure of risk underlies the clinical phenotype.

4 February 2019 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
DHDavid M. Howard
David M. Howard
MAMark J. Adams
Mark J. Adams
TCToni-Kim Clarke
Toni-Kim Clarke
JHJonathan D. Hafferty
Jonathan D. Hafferty
JGJude Gibson
Jude Gibson
AMAndrew M. McIntosh
Andrew M. McIntosh
Major depression is a debilitating psychiatric illness that is typically associated with low mood and anhedonia. Depression has a heritable component that has remained difficult to elucidate with current sample sizes due to the polygenic nature of the disorder. To maximize sample size, we meta-analyzed data on 807,553 individuals (246,363 cases and 561,190 controls) from the three largest genome-wide association studies of depression. We identified 102 independent variants, 269 genes, and 15 genesets associated with depression, including both genes and gene pathways associated with synaptic structure and neurotransmission. An enrichment analysis provided further evidence of the importance of prefrontal brain regions. In an independent replication sample of 1,306,354 individuals (414,055 cases and 892,299 controls), 87 of the 102 associated variants were significant after multiple testing correction. These findings advance our understanding of the complex genetic architecture of depression and provide several future avenues for understanding etiology and developing new treatment approaches.

1 May 2019 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ECeQTLGen Consortium
eQTLGen Consortium
ESEli A. Stahl
Eli A. Stahl
BCBIOS Consortium
BIOS Consortium
TCthe Bipolar Disorder Working Group of the Psychiatric Genomics Consortium
the Bipolar Disorder Working Group of the Psychiatric Genomics Consortium
GBGerome Breen
Gerome Breen
PSPamela Sklar
Pamela Sklar
Bipolar disorder is a highly heritable psychiatric disorder. We performed a genome-wide association study (GWAS) including 20,352 cases and 31,358 controls of European descent, with follow-up analysis of 822 variants with P < 1 × 10−4 in an additional 9,412 cases and 137,760 controls. Eight of the 19 variants that were genome-wide significant (P < 5 × 10−8) in the discovery GWAS were not genome-wide significant in the combined analysis, consistent with small effect sizes and limited power but also with genetic heterogeneity. In the combined analysis, 30 loci were genome-wide significant, including 20 newly identified loci. The significant loci contain genes encoding ion channels, neurotransmitter transporters and synaptic components. Pathway analysis revealed nine significantly enriched gene sets, including regulation of insulin secretion and endocannabinoid signaling. Bipolar I disorder is strongly genetically correlated with schizophrenia, driven by psychosis, whereas bipolar II disorder is more strongly correlated with major depressive disorder. These findings address key clinical questions and provide potential biological mechanisms for bipolar disorder.

15 January 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZZZhihong Zhu
Zhihong Zhu
ZZZhili Zheng
Zhili Zheng
FZFutao Zhang
Futao Zhang
YWYang Wu
Yang Wu
MTMaciej Trzaskowski
Maciej Trzaskowski
JYJian Yang
Jian Yang
Health risk factors such as body mass index (BMI) and serum cholesterol are associated with many common diseases. It often remains unclear whether the risk factors are cause or consequence of disease, or whether the associations are the result of confounding. We develop and apply a method (called GSMR) that performs a multi-SNP Mendelian randomization analysis using summary-level data from genome-wide association studies to test the causal associations of BMI, waist-to-hip ratio, serum cholesterols, blood pressures, height, and years of schooling (EduYears) with common diseases (sample sizes of up to 405,072). We identify a number of causal associations including a protective effect of LDL-cholesterol against type-2 diabetes (T2D) that might explain the side effects of statins on T2D, a protective effect of EduYears against Alzheimer’s disease, and bidirectional associations with opposite effects (e.g., higher BMI increases the risk of T2D but the effect of T2D on BMI is negative).

18 April 2016 in Nature Genetics
Verified
Journal Article
Open access
PDF file
LSLifeLines Cohort Study
LifeLines Cohort Study
AOAysu Okbay
Aysu Okbay
BBBart M L Baselmans
Bart M L Baselmans
JNJan-Emmanuel De Neve
Jan-Emmanuel De Neve
PTPatrick Turley
Patrick Turley
DCDavid Cesarini
David Cesarini
Daniel Benjamin, Meike Bartels, Philipp Koellinger and colleagues report a genome-wide association meta-analysis of subjective well-being, depressive symptoms and neuroticism. The study leverages a large sample size together with genetic correlations between the phenotypes to identify, with high confidence, loci associated with each phenotype. Very few genetic variants have been associated with depression and neuroticism, likely because of limitations on sample size in previous studies. Subjective well-being, a phenotype that is genetically correlated with both of these traits, has not yet been studied with genome-wide data. We conducted genome-wide association studies of three phenotypes: subjective well-being (n = 298,420), depressive symptoms (n = 161,460), and neuroticism (n = 170,911). We identify 3 variants associated with subjective well-being, 2 variants associated with depressive symptoms, and 11 variants associated with neuroticism, including 2 inversion polymorphisms. The two loci associated with depressive symptoms replicate in an independent depression sample. Joint analyses that exploit the high genetic correlations between the phenotypes (|ρ^| ≈ 0.8) strengthen the overall credibility of the findings and allow us to identify additional variants. Across our phenotypes, loci regulating expression in central nervous system and adrenal or pancreas tissues are strongly enriched for association.

14 January 2019 in Nature Genetics
Verified
Journal Article
Open access
PDF file
RLRichard Karlsson Linnér
Richard Karlsson Linnér
PBPietro Biroli
Pietro Biroli
EKEdward Kong
Edward Kong
SMS. Fleur W. Meddens
S. Fleur W. Meddens
RWRobbee Wedow
Robbee Wedow
JBJonathan P. Beauchamp
Jonathan P. Beauchamp
Humans vary substantially in their willingness to take risks. In a combined sample of over 1 million individuals, we conducted genome-wide association studies (GWAS) of general risk tolerance, adventurousness, and risky behaviors in the driving, drinking, smoking, and sexual domains. Across all GWAS, we identified hundreds of associated loci, including 99 loci associated with general risk tolerance. We report evidence of substantial shared genetic influences across risk tolerance and the risky behaviors: 46 of the 99 general risk tolerance loci contain a lead SNP for at least one of our other GWAS, and general risk tolerance is genetically correlated (\(\left| {\hat r_{\mathrm{g}}} \right|\) ~ 0.25 to 0.50) with a range of risky behaviors. Bioinformatics analyses imply that genes near SNPs associated with general risk tolerance are highly expressed in brain tissues and point to a role for glutamatergic and GABAergic neurotransmission. We found no evidence of enrichment for genes previously hypothesized to relate to risk tolerance.